300434 金石亚药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.4155.39910.0413.242-28.960
总资产报酬率 ROA (%)1.9584.0967.5082.527-24.025
投入资产回报率 ROIC (%)2.2124.7999.0382.961-27.372

边际利润分析
销售毛利率 (%)55.38361.38661.33156.74253.890
营业利润率 (%)11.76714.71523.4978.446-85.932
息税前利润/营业总收入 (%)10.66613.68523.1008.633-85.951
净利润/营业总收入 (%)7.3859.98317.1456.275-88.058

收益指标分析
经营活动净收益/利润总额(%)104.629141.79098.556134.423-0.262
价值变动净收益/利润总额(%)-7.745-10.410-4.119-10.3390.235
营业外收支净额/利润总额(%)-7.661-0.521-0.4924.868-0.429

偿债能力分析
流动比率 (X)3.3062.2821.8611.8202.598
速动比率 (X)2.6681.8851.5701.4012.059
资产负债率 (%)14.03621.84124.72521.8960.174
带息债务/全部投入资本 (%)2.5198.5757.7405.2934.507
股东权益/带息债务 (%)3,762.6661,033.3911,152.0381,718.4792,035.153
股东权益/负债合计 (%)606.827354.374300.602343.786463.497
利息保障倍数 (X)-40.494-14.336-82.064-35.094222.655

营运能力分析
应收账款周转天数 (天)31.50925.73522.53717.22320.742
存货周转天数 (天)179.003167.902155.491161.018169.614